Bill Densel

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Check-Cap US, Inc. develops gastrointestinal imaging devices. The company was founded on June 9, 2015 and is headquartered in DE.

Beacon Endoscopic (BE) is a Boston based medical device company innovating in existing interventional endoscopic procedures and developing next generation devices to change the paradigm of surgery. The company is to develop high quality medical devices that reduce healthcare costs through efficiency, safety and the reduction of invasive procedures to help ensure superior clinical outcomes for patients.

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.